Last reviewed 2026-04-23 · How we verify

urine sample

This drug is used to detect the presence of a substance in urine.

This drug is used to detect the presence of a substance in urine. Used for Detection of various substances in urine, including drugs of abuse, pregnancy, and certain medical conditions.

At a glance

Mechanism of action

The drug works by analyzing the chemical composition of urine to identify specific compounds. This is typically done through various chemical tests or immunoassays. The results are then used to diagnose or monitor various medical conditions.

Approved indications

• Detection of various substances in urine, including drugs of abuse, pregnancy, and certain medical conditions

Common side effects

• False positives

Key clinical trials

• Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer (PHASE1)
• Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial (PHASE2)
• Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer (PHASE2)
• USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias (NA)
• Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer (PHASE1)
• A Machine Learning Prediction Model for Postoperative Acute Kidney Injury in Non-Cardiac Surgery Patients
• Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones (PHASE1)
• Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.